The archive · Consumer Apps · Strategic decision · 2016–2026
Honasa's D2C-brand bet: ₹1,701 Cr IPO, a loss-driven crash, then +176% profit
Mamaearth parent Honasa bet a digital-native house of beauty brands could outscale legacy FMCG; its offline/D2C push caused a 2024 crash, then profit comeback.
Honasa Consumer (Mamaearth)
What the business is
Honasa Consumer is a house of digitally-native beauty and personal-care brands — Mamaearth, The Derma Co., Aqualogica, Dr. Sheth's, BBlunt — sold online-first through its own D2C channels, marketplaces and, increasingly, offline retail and salons.
How it started
Founded in 2016 by husband-wife duo Varun and Ghazal Alagh after they could not find toxin-free baby care for their son in India; Mamaearth launched in December 2016 with six products. It reached a ₹700 Cr revenue run-rate by April 2021, raised about $75M from Sequoia India, Sofina, Fireside and others, and listed in November 2023.
What happened
The post-IPO strategy was an offline and distribution push: roughly ₹186 Cr of proceeds for brand marketing, 44 new exclusive brand outlets a year, and a direct-to-consumer distribution overhaul called 'Project Neev'. In Q2 FY25 Honasa reported its first quarterly loss since listing (₹19 Cr) on 7% lower revenue, blaming inventory corrections from the D2C transition; the stock hit the 20% lower circuit at ₹297.25, below its ₹324 IPO price, and Emkay cut its target from ₹600 to ₹300.
How it ended up
Honasa swung back to profit in the Sep 2025 quarter and FY26 delivered net profit of ₹200.2 Cr (+176% YoY) on revenue of ₹2,391.9 Cr (+16%) plus a maiden dividend — a turnaround, though the stock was still down about 17% year-over-year as of Nov 2025.
Background
Honasa Consumer is the parent of Mamaearth and a house of digitally-native beauty brands (The Derma Co., Aqualogica, Dr. Sheth's, BBlunt). Its bet was that a digital-first, listening-driven brand portfolio could outscale legacy FMCG in India's beauty and personal-care market — and, after listing, that pushing offline and direct-to-consumer distribution would deepen the moat rather than crush margins.
Founded in 2016 by Varun and Ghazal Alagh after they could not find toxin-free baby care in India, Mamaearth launched with six products in December 2016 and hit a ₹700 Cr revenue run-rate by April 2021. Honasa listed in November 2023 in a ₹1,701 Cr IPO subscribed 7.61 times, with proceeds earmarked for advertising, exclusive brand outlets and BBlunt salons.
The offline/D2C push broke the model before it worked: Q2 FY25 brought the first loss since listing (₹19 Cr) on falling revenue, blamed on inventory corrections from the 'Project Neev' distribution overhaul. The stock hit the 20% lower circuit at ₹297.25, below its ₹324 IPO price, as brokerages slashed targets.
Honasa then executed its way back: a return to profit in Sep 2025, gross margins around 71%, and FY26 net profit of ₹200.2 Cr (+176%) on ₹2,391.9 Cr revenue with a maiden dividend — a turnaround that kept the original house-of-brands bet intact.
What has to be true
- Toxin-free, ingredient-led products filled a gap Indian parents said existed, giving Mamaearth a defensible story against generic FMCG.
- Listening-based rapid iteration (225 SKUs by Sep 2022) let the house of brands chase demand instead of guessing.
- The post-IPO offline push was the bet's stress test: it caused the 2024 loss, proving distribution transitions are where D2C margins die.
- Management kept the house-of-brands thesis and fixed execution, which is why FY26 profit more than doubled year-over-year.
What can be applied
Going offline is where D2C brands lose their edge: Honasa's distribution overhaul caused its first loss since listing, but fixing execution — not abandoning the bet — brought it back to record profit.
Aftermath
As of May 2026, Honasa is profitable and growing again: FY26 net profit ₹200.2 Cr (+176%), revenue ₹2,391.9 Cr (+16%), younger brands up 40% YoY, gross margins around 71%, and a maiden ₹3-per-share dividend. It is pushing into premium with Lumineve (prestige skincare, Nykaa-exclusive, priced at 2.5x its portfolio) and a 25% stake in oral-care brand Fang, while analysts watch whether those bets scale without denting margins.
Sources
- Inside Mamaearth: How husband-wife duo Varun and Ghazal Alagh built a profitable Rs 700-Cr D2C sensation
- IPO-Bound Mamaearth's Identity Crisis: Offline-First Or D2C & Digital-First?
- Mamaearth Shares Debut At Nearly 2% Premium Over IPO Price
- Mamaearth parent Honasa Consumer shares close 4% higher on debut
- Honasa Consumer stock plunges 20% as firm reports first loss in five quarters
- Honasa Consumer Q4 results: Mamaearth-parent's net profit surges 178% to Rs 69 crore, revenue up 23%
spotted an error? The archive wants to know.
Your turn
You just read one. Describe what you are building, and see who is betting on the same thing.
Free account · 3 free questions · no card